Objective:To evaluate the efficacy and safety of a neoadjuvant gemcitabine and nedaplatin chemotherapy regimen followed by concurrent chemoradiotherapy or radiotherapy alone in locoregionally advanced
The aim of this study was to ensure a high dose of intensity modulated radiation therapy(IMRT) was delivered to tumor tissue with a low dose to normal organs.Seldinger interventional techniques were u
Backgroud: For the locogegionally advanced nasopharyngeal carcinoma (NPC) patients, radiotherapy plus chemotherapy has been the gold standard treatment reiment.However, the cisplatin based chemotherap
Background:A randomized phase 3 trial of the treatment of nasopharyngeal carcinoma compared induction chemotherapy with docetaxel plus cisplatin and fluorouracil (TPF) with cisplatin and fluorouracil
Backgroud:Concurrent chemoradiotherapy(CCRT) has been the back-born of locoreginally advanced nasopharyngeal carcinoma (NPC) patients.We report data from our study to assess the efficacy and adverse e
Objective:To investigate the therapeutic efficacy of computed tomography (CT)-guided permanent percutaneous implantation of iodine-125(125I) for treating recurrent nasopharyngeal cancer.
[背景]颅底骨质破坏被认为是鼻咽癌患者一个预后差的指标，并被归于第七版MCC的T3分类，该分期系统是基于二维常规放射治疗作为主要放疗手段及CT作为主要诊断工具的回顾性研究。然而随着放疗技术的发展特别是调强放疗的普遍应用以及影像技术的发展特别是MRI的应用，颅底骨质破坏在鼻咽癌中的预后价值需要重新评估。[目的]探讨基于MRI的颅底骨质破坏在鼻咽癌调强放疗模式下的预后价值；建立一个基于MRI的颅底骨质
Background: Replanning in intensity-modulated radiotherapy(IMRT) has been reported to improve quality of life and local regional control in patients with nasopharyngeal cancer(NPC).Determination of th
[目的]研究鼻咽癌调强放疗后放射性颞叶损伤的影像及临床特点.[方法]回顾性研究单治疗组2005年3月至2012年1月初治无远处转移鼻咽低分化鳞癌患者行IMRT共260例.依据08分期：Ⅰ期12例(4.6％),Ⅱ期36例(13.8％),Ⅲ期103例(39.6％),Ⅳ期109例(41.9％),局部晚期T3/T4患者共162例,放疗剂量：GTVnx 61.32～76Gy/28～35f,GTVnd 60～
[目的]评价海萝菲(卡波姆凝胶液)治疗头颈部肿瘤患者因放疗或化疗引起口腔黏膜炎餐时疼痛的安全性及有效性.[方法]本研究为随机双盲、安慰剂对照、多中心前瞻性临床研究.主要入选标准：18～70岁，性别不限，鼻咽癌及头颈部恶性肿瘤接受放疗或化疗期间，发生口腔黏膜炎≥Ⅱ级(NCI-CTC V3.0)，三家医院120例受试者知情同意并签署知情同意书.按1∶1随机、双盲法入组，分为：海萝菲试验组(A组)、生理